Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Mocha Jet, Drugdoctor, joseytheoutlawwales, lasers, NASDAQ2020, IB_
Search This Board: 
Last Post: 8/18/2017 4:01:28 PM - Followers: 834 - Board type: Free - Posts Today: 49

Elite Pharmaceuticals, Inc. (ELTP)

About Elite Pharmaceuticals
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
More information including Elite’s proprietary Abuse Resistant Technology can be found at

About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
Products & Pipeline
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at
The list of pipeline products can be found at
Nasrat Hakim, Chairman, President & Chief Executive Officer
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


Miscellaneous Links:
Elite Pharmaceuticals News
SEC Filings

FDA website

Clinical Trials.Gov
Yahoo Finance
Seeking Alpha

ELTP Daily Chart

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Current Report Filing (8-k) 08/09/2017 05:01:18 PM
ELTP News: Quarterly Report (10-q) 08/09/2017 04:30:20 PM
ELTP News: Current Report Filing (8-k) 07/28/2017 12:59:52 PM
ELTP News: Confidential Treatment Order (ct Order) 07/12/2017 05:00:02 PM
ELTP News: Current Report Filing (8-k) 07/12/2017 04:02:10 PM
#268030  Sticky Note My prediction is the FDA will say benefits outweigh Bngo 08/03/17 07:01:11 AM
#260714  Sticky Note Uh, no. WeeZuhl 06/13/17 02:21:47 PM
#247416  Sticky Note HERE is WHAT long term investors need to UNDERSTAND!!! Couch 03/21/17 06:12:24 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#189564  Sticky Note $ELTP SequestOx and ADF Patents lasers 03/18/16 04:29:26 AM
#185967  Sticky Note The only topic here is ELTP. IH Admin [Dan] 02/23/16 09:32:46 PM
#269187   Back at ya dub, were not going anywhere sharkey1 08/18/17 04:16:11 PM
#269186   Definition of desperation namtae 08/18/17 04:01:28 PM
#269185   Gee what a surprise where were they when stockboy 08/18/17 03:38:52 PM
#269184   Definition of desperation WeeZuhl 08/18/17 03:23:02 PM
#269183   Sofa Capital Management Reduces Rating on ELTP to SELL conix 08/18/17 02:35:09 PM
#269182   Elite shares appear abandoned.. Credibility lost. True valuation namtae 08/18/17 01:51:08 PM
#269181   Not to mention that the 95% of savvy Goodtimes93 08/18/17 01:47:54 PM
#269180   Fear Uncertainty and Doubt FUD It Ain't Going namtae 08/18/17 01:19:01 PM
#269179   Elite has fallen to .095 bid namtae 08/18/17 01:14:54 PM
#269178   Still over valued penny per week drop is stockboy 08/18/17 12:45:44 PM
#269177   Sure nasRAT can fix the TMAX issue in stockboy 08/18/17 12:44:27 PM
#269176   Elite will hammerlock the ONLY Generic Abuse Deterrent NASDAQ2020 08/18/17 12:41:10 PM
#269174   You just described my investment perfectly 62bluejay 08/18/17 12:21:07 PM
#269170   I was thinking the same thing. Good to see Dubster watching 08/18/17 12:10:55 PM
#269169   Thanks Bngo, I will be buying more soon, sharkey1 08/18/17 12:05:56 PM
#269168   Elite is a real company trying to make Bngo 08/18/17 12:02:20 PM
#269167   tenor, you are a example of the numerous conix 08/18/17 11:47:54 AM
#269166   Then again Elite could get one or both stockboy 08/18/17 11:22:09 AM
#269165   Just a few more nails to finsih this stockboy 08/18/17 11:22:08 AM
#269164   So far a few have been right all stockboy 08/18/17 11:13:56 AM
#269163   Unfortunately the damage has already for many of tenor15824 08/18/17 11:13:03 AM
#269162   Just a few more nails in elites coffin stockboy 08/18/17 11:11:07 AM
#269161   WOW .095 your 19500 pathways don't mean squat. stockboy 08/18/17 11:10:19 AM
#269160   Thank you! kennyt 335 08/18/17 11:07:20 AM
#269157   The board has gone to pot over the jour_trader 08/18/17 10:49:13 AM
#269148   Canada is contemplating making ALL opiods ADF. NASDAQ2020 08/18/17 10:17:07 AM
#269146   I bet we touch 8 cents today. vanwes1 08/18/17 09:33:15 AM
#269142   Elite will have a HammerLock on ALL these NASDAQ2020 08/18/17 07:28:51 AM
#269141   19.5 Pathways to DollarLand NASDAQ2020 08/18/17 07:18:30 AM
#269140   Has the $40,000,000 share started yet? The lower stockboy 08/18/17 02:26:18 AM
#269139   That's wonderful news. Too bad it didn't start Sixman 08/18/17 01:11:37 AM
#269135   No there wasnt a CT right afterwards, sorry dr_lowenstein 08/17/17 09:48:04 PM
#269134   Wasn't there a CT right afterwards.? NASDAQ2020 08/17/17 06:51:28 PM
#269132   Stock market is not about lovers and haters, Dr_Thorfin 08/17/17 05:58:37 PM
#269131   How much has their current Oxy w/ Epic jour_trader 08/17/17 05:53:12 PM
#269129   10 cents is now resistance not support BostonTrader 08/17/17 05:30:11 PM
#269128   So at this point if you bought ELTP BostonTrader 08/17/17 05:17:23 PM
#269127   10 cents is like a Spartan shield wall rojack14 08/17/17 05:17:03 PM
#269126   That was a long time ago, what came zeus_0100 08/17/17 05:13:05 PM
#269125   Going much lower .01 per week drop over stockboy 08/17/17 04:20:41 PM
#269124   That was being generous stockboy 08/17/17 04:18:16 PM
#269123   Elite closed 10 cents!! namtae 08/17/17 04:00:49 PM
#269122   Elite closing strong.. almost .10 lol namtae 08/17/17 03:49:36 PM
#269117   Broke 10cents. " Buy everything under 10." Lol. vanwes1 08/17/17 02:10:08 PM
#269116   The famous $.068 will be here soon! Goodtimes93 08/17/17 01:04:15 PM
#269115   Some indicators work ...... stockboy 08/17/17 12:57:46 PM
#269112   You mean charts work on these stocks? conix 08/17/17 12:29:07 PM
#269111   I admit, it's sad the see this potentially Dubster watching 08/17/17 12:27:27 PM
#269110   In February Elite had a sit down with NASDAQ2020 08/17/17 12:24:18 PM
#269109   Eltp in a death spiral, death cross continues. stockboy 08/17/17 12:23:24 PM